(Q83169222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Assessment of functional status in patients with invasive carcinoma of the urothelial tract (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

C Kamby

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

L Sengeløv

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

43-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Karnofsky performance status revisited: reliability, validity, and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Platinum analogue combination chemotherapy: cisplatin, carboplatin, and methotrexate in patients with metastatic urothelial tract tumors. A phase II trial with evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Systemic mitomycin C as second-line treatment for metastatic urothelial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Interobserver agreement in the physical diagnosis of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Clinical Symptoms and Length of Survival in Patients With Terminal Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Organ-sparing treatment of advanced bladder cancer: a 10-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Factors affecting the outcome of patients with advanced urothelial cancer following chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Biology and management of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Performance status assessment in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Accuracy of predictions of survival in later stages of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

Prognostic uncertainty in terminal care: can the Karnofsky index help?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2896%2900049-X

7 January 2021

10.1016/S1078-1439(96)00049-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21224135%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference